|
|
Recent Transactions
Over the last 5 years, our team has completed transactions totaling
over 5 million SF and over $1 Billion in consideration. Below is a
full list of recent transactions completed in which the C&W Life
Sciences Group represented the tenant:
| DATE |
CLIENT |
TYPE |
TRANSACTION |
SIZE (SF) |
| Dec. 2011 |
Bio-Edge-Inc |
Tenant |
Lease |
2,800 |
| Nov. 2011 |
Vala Sciences |
Tenant |
Lease |
5,000 |
| Oct. 2011 |
Cibus |
Tenant |
Expansion |
53,400 |
| Sept. 2011 |
Kalypsys |
Tenant |
Lease |
4,400 |
| Aug. 2011 |
Fabrus |
Tenant |
Lease |
3,500 |
| Aug. 2011 |
Optimum Therapeutics |
Tenant |
Sublease |
7,300 |
| July 2011 |
Multimeric |
Tenant |
Lease |
1,200 |
| July 2011 |
Amaratek |
Tenant |
Sublease |
3,700 |
| July 2011 |
Synthetech |
Tenant |
Sublease |
3,700 |
| June 2011 |
Verenium |
Tenant |
Lease |
60,000 |
| June 2011 |
Synthetic Genomics |
Tenant |
Lease |
Undisclosed |
| June 2011 |
Concortis Biosystems |
Tenant |
Lease |
1,100 |
| April 2011 |
Crinetics Pharmaceuticals |
Tenant |
Lease |
2,400 |
| Mar. 2011 |
Kalypsys |
Tenant |
Sublease |
46,000 |
| Mar. 2011 |
Oranoxis |
Tenant |
Lease |
1,500 |
| Mar. 2011 |
SDRMI |
Tenant |
Lease |
2,100 |
| Feb. 2011 |
Synthetic Genomics |
Tenant |
Renewal |
45,000 |
| Jan. 2011 |
Kalypsys |
Tenant |
Lease |
4,900 |
| Jan. 2011 |
Next Therapeutics |
Tenant |
Lease |
29,000 |
| Jan. 2011 |
Amira Pharmaceuticals |
Tenant |
Renewal |
28,000 |
| Dec. 2010 |
Advantageous Systems |
Tenant |
Lease |
1,400 |
| Dec. 2010 |
The Gaia Medical Institute |
Tenant |
Lease |
750 |
| Oct. 2010 |
ActivX |
Tenant |
Recast |
22,000 |
| Oct. 2010 |
Neuraccel Biosciences |
Tenant |
Lease |
1,400 |
| Oct. 2010 |
Sanford Burnham Institute |
Tenant |
Recast |
75,000 |
| Oct. 2010 |
DJK, Inc. |
Tenant |
Lease |
2,500 |
| Oct. 2010 |
Biogen Idec |
Tenant |
Sale |
350,000 |
| Sept. 2010 |
Focus Synthesis |
Tenant |
Lease |
1,500 |
| Sept. 2010 |
UCSD Clinical Labs |
Tenant |
Lease |
90,000 |
| Sept. 2010 |
Althea Technologies |
Tenant |
Recast |
105,000 |
| Aug. 2010 |
Vala Sciences |
Tenant |
Lease |
1,500 |
| Aug. 2010 |
CovX Pharmaceuticals |
Tenant |
Lease |
3,000 |
| Aug. 2010 |
Surya |
Tenant |
Lease |
1,500 |
| July 2010 |
Ventrix |
Tenant |
Lease |
1,000 |
| June 2010 |
Cibus |
Tenant |
Lease |
25,000 |
| May 2010 |
Promosome |
Tenant |
Lease |
1,500 |
| May 2010 |
Biological Dynamics |
Tenant |
Lease |
1,000 |
| May 2010 |
Genomatica |
Tenant |
Recast |
25,000 |
| March 2010 |
Jaleva |
Tenant |
Lease |
1,000 |
| March 2010 |
Synthetic Genomics |
Tenant |
Lease |
500 |
| March 2010 |
Aethlon Medical |
Tenant |
Lease |
1,500 |
| Feb. 2010 |
Nativis |
Tenant |
Lease |
9,000 |
| Dec. 2009 |
Conatus |
Tenant |
Lease |
6,000 |
| Nov. 2009 |
Organovo |
Tenant |
Lease |
4,500 |
| Nov. 2009 |
Targeson |
Tenant |
Lease |
2,000 |
| Oct. 2009 |
Sirion Therapeutics |
Tenant |
Lease |
7,500 |
| Sept. 2009 |
Neurogenetic Pharma |
Tenant |
Lease |
2,000 |
| Aug. 2009 |
Ligand |
Tenant |
Recast |
30,000 |
| Aug. 2009 |
Takeda |
Tenant |
Lease |
40,000 |
| Aug. 2009 |
Synthetic Genomics |
Tenant |
Renewal |
45,000 |
| July 2009 |
Fluorotronics |
Tenant |
Lease |
1,000 |
| June 2009 |
Lilly & Co |
Tenant |
Lease |
165,000 |
| June 2009 |
Private Seller |
Tenant |
Lease |
66,000 |
| April 2009 |
Tavistock |
Tenant |
Lease |
1,500 |
| Mar. 2009 |
The Burnham Institute |
Tenant |
Lease |
20,000 |
| Mar. 2009 |
Avanir |
Tenant |
Sublease |
9,000 |
| Feb. 2009 |
Orphagen |
Tenant |
Lease |
5,000 |
| Feb. 2009 |
Ionian Technologies |
Tenant |
Lease |
11,000 |
| Jan. 2009 |
Zacharon |
Tenant |
Lease |
10,500 |
| Jan. 2009 |
The Burnham Institute |
Tenant |
Lease |
3,000 |
|
